Research ArticleBasic Science Investigations
In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and 18F-Fallypride
Veronika Schönitzer, Florian Haasters, Stefanie Käsbauer, Veronika Ulrich, Erik Mille, Franz Josef Gildehaus, Janette Carlsen, Manuela Pape, Roswitha Beck, Andreas Delker, Guido Böning, Wolf Mutschler, Wolfgang Böcker, Matthias Schieker and Peter Bartenstein
Journal of Nuclear Medicine August 2014, 55 (8) 1342-1347; DOI: https://doi.org/10.2967/jnumed.113.134775
Veronika Schönitzer
1Department of Surgery, Experimental Surgery, and Regenerative Medicine, Ludwig-Maximilians-University Munich, Munich, Germany; and
Florian Haasters
1Department of Surgery, Experimental Surgery, and Regenerative Medicine, Ludwig-Maximilians-University Munich, Munich, Germany; and
Stefanie Käsbauer
1Department of Surgery, Experimental Surgery, and Regenerative Medicine, Ludwig-Maximilians-University Munich, Munich, Germany; and
Veronika Ulrich
1Department of Surgery, Experimental Surgery, and Regenerative Medicine, Ludwig-Maximilians-University Munich, Munich, Germany; and
Erik Mille
2Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
Franz Josef Gildehaus
2Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
Janette Carlsen
2Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
Manuela Pape
2Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
Roswitha Beck
2Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
Andreas Delker
2Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
Guido Böning
2Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
Wolf Mutschler
1Department of Surgery, Experimental Surgery, and Regenerative Medicine, Ludwig-Maximilians-University Munich, Munich, Germany; and
Wolfgang Böcker
1Department of Surgery, Experimental Surgery, and Regenerative Medicine, Ludwig-Maximilians-University Munich, Munich, Germany; and
Matthias Schieker
1Department of Surgery, Experimental Surgery, and Regenerative Medicine, Ludwig-Maximilians-University Munich, Munich, Germany; and
Peter Bartenstein
2Department of Nuclear Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
In this issue
Journal of Nuclear Medicine
Vol. 55, Issue 8
August 1, 2014
In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and 18F-Fallypride
Veronika Schönitzer, Florian Haasters, Stefanie Käsbauer, Veronika Ulrich, Erik Mille, Franz Josef Gildehaus, Janette Carlsen, Manuela Pape, Roswitha Beck, Andreas Delker, Guido Böning, Wolf Mutschler, Wolfgang Böcker, Matthias Schieker, Peter Bartenstein
Journal of Nuclear Medicine Aug 2014, 55 (8) 1342-1347; DOI: 10.2967/jnumed.113.134775
In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and 18F-Fallypride
Veronika Schönitzer, Florian Haasters, Stefanie Käsbauer, Veronika Ulrich, Erik Mille, Franz Josef Gildehaus, Janette Carlsen, Manuela Pape, Roswitha Beck, Andreas Delker, Guido Böning, Wolf Mutschler, Wolfgang Böcker, Matthias Schieker, Peter Bartenstein
Journal of Nuclear Medicine Aug 2014, 55 (8) 1342-1347; DOI: 10.2967/jnumed.113.134775